Aura Biosciences (AURA) Shares Outstanding (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Shares Outstanding (Entity) data on file, last reported at $64.2 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 27.73% year-over-year to $64.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.2 million (up 27.73% YoY) and the FY2025 annual result came in at $63.6 million, up 27.18% from the prior year.
• Shares Outstanding (Entity) advanced to $64.2 million in Q1 2026, from $63.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $64.2 million in Q1 2026 to a low of $29.2 million in Q1 2022.
• A 5-year average of $45.5 million and a median of $49.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 6610.14% — and 2025, when it climbed 1.46%.
• Tracing AURA's Shares Outstanding (Entity) over 5 years: stood at $29.9 million in 2022, then soared by 32.34% to $39.6 million in 2023, then grew by 26.19% to $50.0 million in 2024, then grew by 27.18% to $63.6 million in 2025, then grew by 0.88% to $64.2 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $64.2 million (Q1 2026), $63.6 million (Q4 2025), and $63.0 million (Q3 2025), per Business Quant data.